92 related articles for article (PubMed ID: 23240892)
1. Acid-degradable cationic poly(ketal amidoamine) for enhanced RNA interference in vitro and in vivo.
Lim H; Noh J; Kim Y; Kim H; Kim J; Khang G; Lee D
Biomacromolecules; 2013 Jan; 14(1):240-7. PubMed ID: 23240892
[TBL] [Abstract][Full Text] [Related]
2. Acid-cleavable ketal containing poly(β-amino ester) for enhanced siRNA delivery.
Guk K; Lim H; Kim B; Hong M; Khang G; Lee D
Int J Pharm; 2013 Sep; 453(2):541-50. PubMed ID: 23796834
[TBL] [Abstract][Full Text] [Related]
3. SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles.
Leber N; Kaps L; Aslam M; Schupp J; Brose A; Schäffel D; Fischer K; Diken M; Strand D; Koynov K; Tuettenberg A; Nuhn L; Zentel R; Schuppan D
J Control Release; 2017 Feb; 248():10-23. PubMed ID: 27940184
[TBL] [Abstract][Full Text] [Related]
4. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
[TBL] [Abstract][Full Text] [Related]
5. PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor.
Kim HJ; Oba M; Pittella F; Nomoto T; Cabral H; Matsumoto Y; Miyata K; Nishiyama N; Kataoka K
J Drug Target; 2012 Jan; 20(1):33-42. PubMed ID: 22066783
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of endosomolytic biocompatible peptides as carriers for siRNA delivery.
Xu W; Pan R; Zhao D; Chu D; Wu Y; Wang R; Chen B; Ding Y; Sadatmousavi P; Yuan Y; Chen P
Mol Pharm; 2015 Jan; 12(1):56-65. PubMed ID: 25378277
[TBL] [Abstract][Full Text] [Related]
7. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
8. Fully biodegradable and cationic poly(amino oxalate) particles for the treatment of acetaminophen-induced acute liver failure.
Kim H; Kim Y; Guk K; Yoo D; Lim H; Kang G; Lee D
Int J Pharm; 2012 Sep; 434(1-2):243-50. PubMed ID: 22664461
[TBL] [Abstract][Full Text] [Related]
9. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.
Khoury M; Louis-Plence P; Escriou V; Noel D; Largeau C; Cantos C; Scherman D; Jorgensen C; Apparailly F
Arthritis Rheum; 2006 Jun; 54(6):1867-77. PubMed ID: 16729293
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages.
He C; Yin L; Tang C; Yin C
Biomaterials; 2013 Apr; 34(11):2843-54. PubMed ID: 23347838
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Hepatic Inflammation via Systemic siRNA Delivery by Membrane-Disruptive and Endosomolytic Helical Polypeptide Hybrid Nanoparticles.
He H; Zheng N; Song Z; Kim KH; Yao C; Zhang R; Zhang C; Huang Y; Uckun FM; Cheng J; Zhang Y; Yin L
ACS Nano; 2016 Feb; 10(2):1859-70. PubMed ID: 26811880
[TBL] [Abstract][Full Text] [Related]
12. Controlled delivery of plasmid DNA and siRNA to intracellular targets using ketalized polyethylenimine.
Shim MS; Kwon YJ
Biomacromolecules; 2008 Feb; 9(2):444-55. PubMed ID: 18186606
[TBL] [Abstract][Full Text] [Related]
13. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.
Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L
Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952
[TBL] [Abstract][Full Text] [Related]
14. Dual mode polyspermine with tunable degradability for plasmid DNA and siRNA delivery.
Shim MS; Kwon YJ
Biomaterials; 2011 Jun; 32(16):4009-20. PubMed ID: 21371749
[TBL] [Abstract][Full Text] [Related]
15. N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver.
Wang HX; Xiong MH; Wang YC; Zhu J; Wang J
J Control Release; 2013 Mar; 166(2):106-14. PubMed ID: 23266452
[TBL] [Abstract][Full Text] [Related]
16. Endosomolytic bioreducible poly(amido amine disulfide) polymer conjugates for the in vivo systemic delivery of siRNA therapeutics.
Parmar RG; Busuek M; Walsh ES; Leander KR; Howell BJ; Sepp-Lorenzino L; Kemp E; Crocker LS; Leone A; Kochansky CJ; Carr BA; Garbaccio RM; Colletti SL; Wang W
Bioconjug Chem; 2013 Apr; 24(4):640-7. PubMed ID: 23496378
[TBL] [Abstract][Full Text] [Related]
17. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
[TBL] [Abstract][Full Text] [Related]
18. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape.
Bartz R; Fan H; Zhang J; Innocent N; Cherrin C; Beck SC; Pei Y; Momose A; Jadhav V; Tellers DM; Meng F; Crocker LS; Sepp-Lorenzino L; Barnett SF
Biochem J; 2011 Apr; 435(2):475-87. PubMed ID: 21265735
[TBL] [Abstract][Full Text] [Related]
19. The box A domain of high mobility group box-1 protein as an efficient siRNA carrier with anti-inflammatory effects.
Lee S; Song H; Kim HA; Oh B; Lee DY; Lee M
J Cell Biochem; 2012 Jan; 113(1):122-31. PubMed ID: 21898538
[TBL] [Abstract][Full Text] [Related]
20. Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(beta-amino esters).
Vandenbroucke RE; De Geest BG; Bonné S; Vinken M; Van Haecke T; Heimberg H; Wagner E; Rogiers V; De Smedt SC; Demeester J; Sanders NN
J Gene Med; 2008 Jul; 10(7):783-94. PubMed ID: 18470950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
